Trends in Biochemical Sciences
Mechanism of the nuclear receptor molecular switch
Section snippets
Specific recognition of a small-molecule ligand
There are now numerous structures of nuclear receptor ligand-binding domains (LBDs) bound to small molecules [15]. Such molecules include the natural ligands of the receptor and synthetic agonists and antagonists, as well as adventitiously bound molecules that resemble the natural ligands. By contrast, there are rather few structures of an LBD in which there is no small molecule bound.
The first thing to note from the structures is that all of the LBDs share a common, primarily helical,
Co-regulators for recruiting large complexes
A chief goal of the nuclear receptor field has been to identify the mechanisms and proteins involved in mediating the activation or repression of the receptor itself: in other words, how does ligand binding translate into regulation of transcription? This question remains to be answered in full but, at least from the point of view of the receptors, we now have a good understanding of the next step in the signalling process.
This progress has been the result of the identification of proteins that
LBDs as molecular sensors
The structural studies discussed above have revealed much of the basis of specific ligand recognition and the nature of the various co-regulator complexes. There is a difference, however, between understanding the various structures and understanding how the molecular switch functions – in other words, the mechanism through which the ligands cause a switch in the choice of co-regulator. The problem is that the structures do not provide a clear explanation for why, in the ligand-free receptor,
Concluding remarks
The realization that the dynamic behaviour of the LBD is key to the mechanism of the molecular switch explains some hitherto puzzling observations about nuclear receptors. In particular, it explains how selective modulators can fine-tune the activity of the receptor [57]. Hence, the switch is not like a regular on–off light switch, but is more like a dimmer switch. This in turn explains why some receptors, such as RAR-related orphan receptor-β (RORβ) and constitutive androstane receptor (CAR),
Acknowledgements
Work in the authors' laboratories was supported by the Royal Society, the Human Frontier Science Program (HFSP) and a Research Training Network of the European Commission (FP5), by a Research Award from the Boehringer Ingelheim Fund (to L.N.), and by a grant from the Hungarian Scientific Research Fund (T034434 to L.N.). L.N. is an International Scholar of the Howard Hughes Medical Institute and an European Molecular Biology Organization (EMBO) Young Investigator.
References (70)
- et al.
The RXR heterodimers and orphan receptors
Cell
(1995) Molecular genetics of acute promyelocytic leukemia
Trends Genet.
(1999)Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist
J. Steroid Biochem.
(1988)Crystal structure of the ligand binding domain of the human nuclear receptor PPARγ
J. Biol. Chem.
(1998)Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor
J. Mol. Biol.
(2003)Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects
J. Biol. Chem.
(2001)The Drosophila orphan nuclear receptor DHR38 mediates an atypical ecdysteroid signaling pathway
Cell
(2003)Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1
Mol. Cell
(2003)The transcriptional coactivators p300 and CBP are histone acetyltransferases
Cell
(1996)Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
Cell
(1997)
Molecular determinants of the balance between co-repressor and co-activator recruitment to the retinoic acid receptor
J. Biol. Chem.
The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
Cell
Ligand-dependent conformational changes in thyroid hormone and retinoic acid receptors are potentially enhanced by heterodimerization with retinoic X receptor
J. Steroid Biochem. Mol. Biol.
Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding
Mol. Cell
Ligand-induced stabilization of PPARγ monitored by NMR spectroscopy: implications for nuclear receptor activation
J. Mol. Biol.
Structure of the PPARα and -γ ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family
Structure
Allosteric control of ligand selectivity between estrogen receptors α and β: implications for other nuclear receptors
Mol. Cell
Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter
Cell
DNA binding domains in diverse nuclear receptors function as nuclear export signals
Curr. Biol.
Beyond zinc fingers: steroid hormone receptors have a novel structural motif for DNA recognition
Trends Biochem. Sci.
Nuclear-receptor interactions on DNA-response elements
Trends Biochem. Sci.
Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands
J. Biol. Chem.
Hormone evolution: the key to signalling
Nature
A receptor molecule for estrogens: studies using a cell-free system
Proc. Natl. Acad. Sci. U. S. A.
Mechanism of action of the female sex hormones
Annu. Rev. Biochem.
The steroid and thyroid hormone receptor superfamily
Science
The nuclear receptor superfamily
J. Cell Sci.
Origins and evolutionary diversification of the nuclear receptor superfamily
Cell. Mol. Life Sci.
Nuclear receptors and lipid physiology: opening the X-files
Science
In vivo functional analysis of the Hoxa-1 3′ retinoic acid response element (3′RARE)
Development
A genetic dissection of the retinoid signalling pathway in the mouse
Proc. Nutr. Soc.
Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy
Breast Cancer Res.
Roles of PPARs in health and disease
Nature
Structural studies on nuclear receptors
Cell. Mol. Life Sci.
A canonical structure for the ligand-binding domain of nuclear receptors
Nat. Struct. Biol.
Cited by (323)
Discriminating functional and non-functional nuclear-receptor ligands with a conformational selection-inspired machine learning algorithm
2023, Cell Reports Physical ScienceStructure function relationships of VDR ligands
2023, Feldman and Pike's Vitamin D: Volume One: Biochemistry, Physiology and DiagnosticsReceptors and drug-metabolizing enzymes: From function to regulation
2022, Biochemistry of Drug Metabolizing Enzymes: Trends and ChallengesHow nuclear receptors transition between active and inactive forms: An energetic perspective
2024, Journal of Chemical Physics